EPIC: A Phase 3 Trial of Ponatinib Compared With Imatinib in CP-CML Patients

著录项

• 来源
  《Clinical lymphoma, myeloma & leukemia》 |2015年第1期|共1页
• 作者

  Lipton Jeffrey H.; Chuah Charles; Guerci-Bresler Agnes; Rosti Gianantonio; Simpson David; Lustgarten Stephanie; Rivera Victor M.; Clackson Tim; Haluska Frank G.; Baccarani Michele; Cortes Jorge E.; Guilhot Francois; Hochhaus Andreas; Hughes Timothy P.; Kantarjian Hagop; Shah Neil P.; Talpaz Moshe; Deininger Michael W.;

  展开▼
• 作者单位

  Univ Toronto Prince Margaret Canc Ctr Toronto ON M5S 1A1 Canada;

  Singapore Gen Hosp Duke NUS Grad Med Sch Singapore Singapore;

  Hop Brabois Vandoeuvre Les Nancy France;

  SOrsola Malpighi Univ Hosp Bologna Italy;

  North Shore Hosp New York NY USA;

  ARIAD Pharmaceut Inc Cambridge MA USA;

  ARIAD Pharmaceut Inc Cambridge MA USA;

  ARIAD Pharmaceut Inc Cambridge MA USA;

  ARIAD Pharmaceut Inc Cambridge MA USA;

  SOrsola Malpighi Univ Hosp Bologna Italy;

  Univ Texas MD Anderson Canc Ctr Houston TX USA;

  Jena Univ Hosp Jena Germany;

  Inst Med &

  Vet Sci Adelaide SA Australia;

  Univ Texas MD Anderson Canc Ctr Houston TX USA;

  Univ Calif San Francisco San Francisco CA 94143 USA;

  Univ Michigan Comprehens Canc Ctr Ann Arbor MI 48109 USA;

  Univ Utah Huntsman Canc Inst Salt Lake City UT 84112 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词